News

Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F

Jilin, China, May 23, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today announced that it has received a letter from the NASDAQ Stock Market, dated May 20, 2025 (the “Delinquency Letter”), notifying the Company that it is not in compliance with the requirements for continued listing set forth in NASDAQ Listing Rule 5250(c)(1) because it did not timely file its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “2024 Annual Report”).

05/23/2025

Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option

Jilin, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccine in China, today announced that the underwriter of its initial public offering (the "Offering") have exercised in full their option to purchase an additional 225,000 ordinary shares at a public offering price of $4.00 per ordinary share to cover over-allotments. Gross proceeds of the Company's initial public offering, including the exercise of the over-allotment, totaled $6.9 million, before deducting underwriting discounts and other related expenses. The ordinary shares began trading on the Nasdaq Capital Market on January 7, 2025 under the ticker symbol “ZYBT.”

01/14/2025

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

What is Zhengye Biotechnology Holding Limited Ordinary Shares's stock price?

The price of Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) is 6.04 and it was updated on 2025-06-30 13:00:26.

Is Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) overvalued or undervalued?

Currently Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) is in undervalued.

News

From:

To:

News
U.S. IPO Weekly Recap: Flowco Launches First Major IPO Of 2025 As Smithfield, Others Join The Pipeline Three very small Asian issuers and one blank check company listed in the US this past week, though the biggest headlines came from a sizable launch and notable new filings. Energy equipment and services provider Flowco launched the year's first major IPO, planning to raise $392 million and list in the week ahead. Two IPOs are currently scheduled in the week ahead, although some other small issuers may join the calendar throughout the week. Sat, Jan. 11, 2025
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering Jilin, China, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccine in China, today announced the closing of its initial public offering (the "Offering") of 1,500,000 ordinary shares at a public offering price of US$4.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and commenced trading on January 7, 2025 under the ticker symbol "ZYBT." Wed, Jan. 08, 2025
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering Jilin, China, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccine in China, today announced the pricing of its initial public offering (the "Offering") of 1,500,000 ordinary shares at a public offering price of US$4.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on January 7, 2025 under the ticker symbol "ZYBT." The Offering is expected to close on or about January 8, 2025, subject to the satisfaction of customary closing conditions. Mon, Jan. 06, 2025
Zhengye Biotechnology's Growth Slows As It Seeks U.S. IPO Zhengye Biotechnology Holding Limited has filed for a $20 million IPO to raise capital for its acquisition program and new development capabilities. The company's revenue has declined, but it still maintains positive profits. The global animal vaccines market is expected to grow at a CAGR of 9.4% through 2030, presenting a significant opportunity for Zhengye. Fri, Jan. 12, 2024

SEC Filings

SEC Filings
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - 6-K - Current report SEC Filings 05/23/2025
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - NT 20-F SEC Filings 04/29/2025
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - 6-K - Current report SEC Filings 04/03/2025
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - 6-K - Current report SEC Filings 03/06/2025
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - SCHEDULE 13G SEC Filings 02/21/2025
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - 6-K - Current report SEC Filings 01/14/2025
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - 6-K - Current report SEC Filings 01/08/2025
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - 424B4 SEC Filings 01/07/2025
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - CERT SEC Filings 01/06/2025
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - EFFECT SEC Filings 12/23/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - 8-A12B SEC Filings 12/19/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - POS AM SEC Filings 12/09/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - FWP SEC Filings 11/21/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - POS AM SEC Filings 11/15/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - EFFECT SEC Filings 10/01/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - CORRESP SEC Filings 09/26/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - F-1/A SEC Filings 09/18/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - FWP SEC Filings 08/27/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - F-1/A SEC Filings 08/22/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - FWP SEC Filings 06/27/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - FWP SEC Filings 06/21/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - F-1/A SEC Filings 06/14/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - CORRESP SEC Filings 06/14/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - UPLOAD SEC Filings 06/04/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - F-1/A SEC Filings 05/15/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - F-1 SEC Filings 01/09/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - CORRESP SEC Filings 01/09/2024
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - UPLOAD SEC Filings 12/27/2023
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - DRSLTR SEC Filings 12/14/2023
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - DRS/A SEC Filings 12/14/2023
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - UPLOAD SEC Filings 11/28/2023
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - DRSLTR SEC Filings 11/17/2023
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - DRS/A SEC Filings 11/17/2023
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - UPLOAD SEC Filings 10/17/2023
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - DRSLTR SEC Filings 09/28/2023
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - DRS/A SEC Filings 09/28/2023
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - UPLOAD SEC Filings 09/01/2023
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) - DRS SEC Filings 08/04/2023

Press Releases

StockPrice Release
Zhengye biotechnology holding limited receives nasdaq notice related to late filing of form 20-f 05/23/2025
Zhengye biotechnology holding limited announces full exercise of underwriters' over-allotment option 01/14/2025
Zhengye biotechnology holding limited announces closing of initial public offering 01/08/2025
Zhengye biotechnology holding limited announces pricing of initial public offering 01/06/2025

Unlock

ZYBT Ratings Summary

ZYBT Quant Ranking

What is Zhengye Biotechnology Holding Limited Ordinary Shares's stock price?

Is Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) overvalued or undervalued?

Company Details

Ratings

Quant Factor Grades

Trading

Dividend Grades

Dividend

Earnings

Valuation

Growth

Performance

Momentum

Profitability

Risk

Ownership

Debt